Skip to main content

D. E. Shaw & Co., Inc.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1009207 New York, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$36,435,896
-$9,752,327 QoQ
Shares Held
569,756
-40.6% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 264 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 KNSA
Kiniksa Pharmaceuticals International, plc
This page
569,756 $36,435,896

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,435,896 569,756
2026-03-31 $46,188,223 959,257
2025-12-31 $51,216,865 1,241,621
2025-09-30 $44,040,441 1,134,186
2025-06-30 $21,895,408 791,305
2025-03-31 $8,833,915 397,745
2024-12-31 $6,329,738 320,007
2024-09-30 $8,021,715 320,997
2024-06-30 $3,167,328 169,648